Basic study on Enhancement Effect on DNA vaccine in Hepatitis type C
Project/Area Number |
11670528
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Jichi Medical School |
Principal Investigator |
MORIYAMA Takashi Jichi Medical School, Department of Medicine, Assistant Professor, 医学部, 講師 (10240706)
|
Co-Investigator(Kenkyū-buntansha) |
KANEKO Takashi Jichi Medical School, Department of Medicine, Assistant, 医学部, 助手 (10254913)
|
Project Period (FY) |
1999 – 2000
|
Project Status |
Completed (Fiscal Year 2000)
|
Budget Amount *help |
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2000: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1999: ¥3,000,000 (Direct Cost: ¥3,000,000)
|
Keywords | hepatitis C virus / DNA vaccine / cytotoxic T lymphocyte / dendritic cell |
Research Abstract |
We tried to induce a T cell response to hepatitic C virus (HCV) NS5A protein by using a DNA vaccine in mice. We immunized mice with a plasmid encoding HCV NS5A region alone or with an adjuvant plasmid encoding IL-2, GM-CSF, or CD86. Neither of them induced a cytotoxic T lymphocyte (CTL) response of a siginificant magnitude. Next we induced mature dendritic cells with IL-4 and GM-CSF from bone marrow cells. We immunized mice with dencritic cells pulsed with reportedly immunogenic CTL epitopes. None of these mice showed a better T cell response yet.
|
Report
(3 results)
Research Products
(4 results)